Suchergebnisse - "Kim, Richard B"

PubPharm (426)

1

HLADQA1∗05G>A Genetic Screening Promotes the Safe Delivery of Combination Therapy in Inflammatory Bowel Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Wilson, A. | Chande, N. | Ponich, T. | +3

2

Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis

enthalten in: The European journal of health economics : HEPAC : health economics in prevention and care | 2024

von Situ, M. | Schwarz, U. | Zou, G. | +4

3

Common dihydropyrimidinase ( DPYS ) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort

enthalten in: Pharmacogenetics and genomics | 2024

von Medwid, S. | Mailloux, J. | Wigle, T. | +1

4

Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada

enthalten in: PharmacoEconomics | 2024

von Hafeez, A. | Cipriano, L. | Kim, R. | +3

5

Patients' Experiences of a Precision Medicine Clinic

enthalten in: Journal of patient experience | 2024

von Barrett, D. | Sibalija, J. | Kim, R.

6

High-Throughput Computing to Automate Population-Based Studies to Detect the 30-Day Risk of Adverse Outcomes After New Outpatient Medication Use in Older Adults with Chronic Kidney Disease : A Clinical Research Protocol

enthalten in: Canadian journal of kidney health and disease | 2024

von Abdullah, S. | Rostamzadeh, N. | Muanda, F. | +6

7

Low-Dose Methotrexate and Serious Adverse Events Among Older Adults With Chronic Kidney Disease

enthalten in: JAMA network open | 2023

von Muanda, F. | Blake, P. | Weir, M. | +6

8

Genetic Variation in miR-27a Is Associated with Fluoropyrimidine-Associated Toxicity in Patients with Dihydropyrimidine Dehydrogenase Variants after Genotype-Guided Dose Reduction

enthalten in: International journal of molecular sciences | 2023

von Medwid, S. | Wigle, T. | Ross, C. | +1

9

Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada

enthalten in: PharmacoEconomics | 2023

von Hafeez, A. | Cipriano, L. | Kim, R. | +3

10

Adverse events with quetiapine and clarithromycin coprescription : A population-based retrospective cohort study

enthalten in: Health science reports | 2023

von Yau, K. | McArthur, E. | Jeyakumar, N. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[43]